Drug Trial Radar · NCT06319456
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
Last checked: Nov 19, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
344
Planned (sponsor's estimate)
Start
Apr 7, 2024
Primary completion
Aug 2027
Study completion Aug 2028
Sponsor
- Lead sponsor
- Ascentage Pharma Group Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a global, multicenter, randomized, open-label, Phase III confirmatory study to investigate the efficacy and safety of Lisaftoclax (APG-2575) in combination with Acalabrutinib in patients with newly diagnosed CLL/SLL.
Conditions
- CLL/SLL
Interventions
Lisaftoclax (APG-2575)Drug
QD, oral administration, every 28 days for a dosing cycle.
AcalabrutinibDrug
BID, oral administration, every 28 days for a dosing cycle.
FludarabineDrug
Every 28 days for a treatment cycle, administration of 6 cycles.
Cyclophosphamide,CTXDrug
Every 28 days for a treatment cycle, administration of 6 cycles.
RituximabDrug
Every 28 days for a treatment cycle, administration of 6 cycles.
ChlorambucilDrug
Every 28 days for a treatment cycle, administration of 6 cycles.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progress Free Survival (PFS)Time frame: Up to 1 year
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China · Not yet recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China · Recruiting
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China · Recruiting
The affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China · Not yet recruiting
Henan Provincial Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Not yet recruiting
The Second Xiangya Hospital of Center South University
Changsha, Hunan, China · Not yet recruiting
Tongji Hospital of Tongji University
Shanghai, Shanghai Municipality, China · Not yet recruiting
Hematology Hospital of the Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.